抗体
选项
-
CD235a Mouse mAb关联靶标: GYPA
- 简短描述: mAb (HIR2); Mouse anti Human CD235a Antibody; Flow; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2b
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIR2
- 偶联: Unconjugated
-
CD235a Mouse mAb (Biotin)关联靶标: GYPA
- 简短描述: mAb (HIR2); Mouse anti Human CD235a Antibody (Biotin); Flow
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2b
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIR2
- 偶联: Biotin
-
CD235a Mouse mAb (FITC)关联靶标: GYPA
- 简短描述: mAb (HIR2); Mouse anti Human CD235a Antibody (FITC); Flow
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2b
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIR2
- 偶联: FITC
-
CD235a Mouse mAb (APC)关联靶标: GYPA
- 简短描述: mAb (HIR2); Mouse anti Human CD235a Antibody (APC); Flow
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2b
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIR2
- 偶联: APC
-
CD40 Mouse mAb关联靶标: CD40
- 简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody; in vitro CD40 stimulation, Functional assays, Flow; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: Unconjugated
-
-
CD235a Mouse mAb (PE)关联靶标: GYPA
- 简短描述: mAb (HIR2); Mouse anti Human CD235a Antibody (PE); Flow
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2b
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIR2
- 偶联: PE
-
CD40 Mouse mAb关联靶标: CD40
- 简短描述: CD40 小鼠单克隆
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: Unconjugated
-
CD40 Mouse mAb (Biotin)关联靶标: CD40
- 简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (Biotin); Flow Cytometry
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: Biotin
-
CD40 Mouse mAb (AF647)关联靶标: CD40
- 简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (AF647); Flow Cytometry
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: AF647
-
CD40 Mouse mAb (PE-Cy5)关联靶标: CD40
- 简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (PE-Cy5); Flow Cytometry
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: PE-Cy5
-
CD40 Mouse mAb (FITC)关联靶标: CD40
- 简短描述: mAb (G28.5); Mouse anti Human CD40 Antibody (FITC); Flow Cytometry
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: G28.5
- 偶联: FITC
首页
400-620-6333











